Lipocine
LPCN
Lipocine (LPCN) news
Recent news
Lipocine appoints Michael J. Grissinger to board of directors
AInvest Wire · Aug 3, 2026Lipocine Q2 GAAP EPS $(0.56) beats $(0.78) estimate, sales $89.565k Miss $290.000k estimate
AInvest Wire · Aug 8, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
